Nanomedicine Market to be Worth $410.15 Billion by 2030: Grand View Research, Inc.

Read 150 page full market research report, "Nanomedicine Market Size, Share & Trends Analysis Report By Application (Drug Delivery), By Indication (Clinical Oncology, Infectious Diseases), By Molecule Type, By Region, And Segment Forecasts, 2023 - 2030", published by Grand View Research. Read 150 page full market research report, " Nanomedicine Market Size, Share & Trends Analysis Report By Application (Drug Delivery), By Indication (Clinical Oncology, Infectious Diseases), By Molecule...

Read 150 page full market research report, "Nanomedicine Market Size, Share & Trends Analysis Report By Application (Drug Delivery), By Indication (Clinical Oncology, Infectious Diseases), By Molecule Type, By Region, And Segment Forecasts, 2023 - 2030", published by Grand View Research.

Nanomedicine Market Growth & Trends

The adoption of nanomedicines is driven by the rise in the prevalence of chronic diseases like cancer and cardiovascular disease. Additionally, the demand for nanomedicine is expanding due to the growing elderly population, and the increase in patients with high blood pressure, obesity, and other cardiovascular diseases. For instance, as per the American Cancer Society, in 2022, an estimated 1.9 million new cancer cases and 609,360 cancer-related deaths were expected in the U.S. alone.

Furthermore, the need for nanomedicines to cure a wide range of illnesses has increased as a result of the COVID-19 pandemic. The development of new approaches for the detection, diagnosis, and cure of the COVID-19 virus as well as other viral infections was made possible by the development of nanomedicine applications. For instance, in November 2020, BioNtech and Pfizer announced the full results of the phase 3 clinical study for the COVID-19 vaccine. They rapidly manufactured vaccinations for testing and regulatory approval using a known technique for encapsulating therapeutic nucleic acid molecules in lipid nanoparticles. Additionally, due to an increase in activities for research and development for nanomedicines across all regions, fueling the market growth.

The developing technologies for drug delivery are important elements that are expected to accelerate the growth of the global market. Also, it is anticipated that the rising popularity of nanomedicine across a variety of applications will fuel the expansion of the nanomedicine industry. Furthermore, it is predicted that the increase in government funding and support will positively affect market growth in the coming years.

New potential opportunities for the expansion of the nanomedicine industry in the upcoming years will be provided by the rise in the out-licensing of nano drugs and the expansion of healthcare facilities in developing nations. Over the past few decades, the US FDA has authorized the commercialization of about 100 nanomedicine applications and devices. As a result, growing interest in nanotechnology's potential medical use is a notable breakthrough in the medical field and further drives market growth.

The rising investment flow in R&D is also driving the nanomedicine industry growth. For instance, in August 2022, South Korea's Life Science Fund declared an investment of over USD 14 million (19 billion won) in Senda Biosciences Inc., a U.S.-based biotechnology firm involved in the creation of nanoparticle-based drug delivery products. Such investments indicate promising growth opportunities for the nanomedicine industry in the near future.

Nanomedicine Market Segmentation

Grand View Research has segmented the global nanomedicine market based on application, indication, molecule type, and region:

Nanomedicine Market - Application Outlook (Revenue, USD Billion, 2018 - 2030)

Nanomedicine Market - Indication Outlook (Revenue, USD Billion, 2018 - 2030)

Nanomedicine Market - Molecule Type Outlook (Revenue, USD Billion, 2018 - 2030)

Nanomedicine Market - Regional Outlook (Revenue, USD Billion, 2018 - 2030)

List of Key Players in the Nanomedicine Market

Check out more related studies published by Grand View Research:

Browse through Grand View Research's  Pharmaceuticals Industry Research Reports.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com
Grand View Compass | Astra ESG Solutions
Follow Us: LinkedIn | Twitter

Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/nanomedicine-market-to-be-worth-410-15-billion-by-2030-grand-view-research-inc-301833030.html